Cyanine7 NHS ester
目录号 | 数量 | 价格 | 提前通知时间 | 购买此产品 |
---|---|---|---|---|
15020 | 1 mg | $125 | 现货 | |
25020 | 5 mg | $260 | 现货 | |
45020 | 25 mg | $510 | 现货 | |
55020 | 50 mg | $895 | 现货 | |
65020 | 100 mg | $1490 | 现货 |
Amine reactive Cyanine7, near infrared fluorescent dye, an improved analog of Cy7®.
NIR fluorophores can be used to take advantage of near infrared window of biological tissues - increased transparency of tissues in this spectral region allows to carry out in vivo imaging.
This reagent can be utilized to produce Cyanine7-labeled biomolecules for subsequent use in various in vivo research, and drug design related experiments.
The structure of Cyanine7 features rigidized design of central polymethyne chain. This molecular reinforcement allows to increase quantum yield by 20% compared with parent structure, increasing fluorescence brightness.
This reagent requires organic co-solvent for the labeling (please see Recommended Protocols section below). Water-soluble Cyanine7 NHS ester is also available, and recommended for protein NIR labeling.
顾客还购买了这个产品
Cyanine5 carboxylic acid
Cyanine5 carboxylic acid, unactivated dye.BDP TR azide
BDP TR is a red-emitting fluorophore for the ROX channel. This is an azide for copper-catalyzed and copper-free сlick chemistry conjugation.Cyanine5.5 NHS ester
Cyanine5.5 NHS is far-red / near-infrared amine-reactive dye.并获得免费的快递服务
General properties
Appearance: | dark green solid |
Molecular weight: | 733.64 |
CAS number: | 2408482-09-5 |
Molecular formula: | C41H48N3BF4O4 |
Solubility: | soluble in organic solvents (DMSO, DMF, dichloromethane), low solubility in water |
Quality control: | NMR 1H, HPLC-MS (95%) |
Storage conditions: | Storage: 12 months after receival at -20°C in the dark. Transportation: at room temperature for up to 3 weeks. Avoid prolonged exposure to light. Desiccate. |
安全数据表(MSDS): | 下载 |
产品规格 |
Spectral properties
Excitation/absorption maximum, nm: | 750 |
ε, L⋅mol−1⋅cm−1: | 199000 |
Emission maximum, nm: | 773 |
Fluorescence quantum yield: | 0.3 |
CF260: | 0.022 |
CF280: | 0.029 |
产品引用
- Ehrman, R.N.; Brohlin, O.R.; Wijesundara, Y.H.; Kumari, S.; Trashi, O.; Howlett, T.S.; Trashi, I.; Herbert, F.C.; Raja, A.; Koirala, S.; Tran, N.; Al-Kharji, N.M.; Tang, W.; Senarathna, M.C.; Hagge, L.M.; Smaldone, R.A.; Gassensmith, J.J. A scalable synthesis of adjuvanting antigen depots based on metal–organic frameworks. Chemical Science, 2024, 15(8), 2731-2744. doi: 10.1039/d3sc06734c
- Seo, H.S.; Han, J.-H.; Lim, J.; Bae, G.-H.; Byun, M.J.; Wang, C.-P.J.; Han, J.; Park, J.; Park, H.H.; Shin, M.; Park, T.-E.; Kim, T.-H.; Kim, S.-N.; Park, W.; Park, C.G. Enhanced Post-Surgical Cancer Treatment Using Methacrylated Glycol Chitosan Hydrogel for Sustained DNA/Doxorubicin Delivery and Immunotherapy. Biomaterials Research, 2024, 28, 0008. doi: 10.34133/bmr.0008
- Ehrman, R. N.; Brohlin, O. R.; Wijesundara, Y. H.; Kumari, S.; Trashi, I.; Trashi, O.; Howlett, T. S.; Herbert, F. C.; Raja, A.; Koirala, S.; Tran, N.; Al-Kharji, N. M.; Hagge, L. M.; Gassensmith, J. A Scalable Synthesis of Adjuvanting Antigen Depots Based on Met-al-Organic Frameworks. ChemRxiv, 2023, preprint. doi: 10.26434/chemrxiv-2023-gtl30
- Itzhaki, E.; Chausky-Barzakh, E.; Atkins, A.; Bareket-Samish, A.; Stemmer, S. M.; Margel, S.; Moskovits, N. Tumor-Targeted Poly(ArgGlyAsp) Nanocapsules for Personalized Cancer Therapy – In Vivo Study. Advanced Therapeutics, 2023, 6(6), 2200337. doi: 10.1002/adtp.202200337